Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Daniel Bowles

Concepts (347)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
30
2024
2051
3.580
 Why?
Head and Neck Neoplasms
16
2023
533
3.090
 Why?
Salivary Gland Neoplasms
8
2023
33
3.050
 Why?
Carcinoma, Squamous Cell
14
2019
620
2.380
 Why?
Protein Kinase Inhibitors
14
2024
872
2.320
 Why?
Pyridines
11
2024
475
2.140
 Why?
Thyroid Neoplasms
9
2024
309
2.030
 Why?
Neoplasm Recurrence, Local
7
2023
958
1.780
 Why?
Molecular Targeted Therapy
7
2021
385
1.770
 Why?
Carcinoma, Non-Small-Cell Lung
8
2023
1045
1.760
 Why?
Antineoplastic Combined Chemotherapy Protocols
14
2024
1559
1.660
 Why?
Neoplasms
20
2024
2464
1.620
 Why?
Protein-Tyrosine Kinases
4
2021
430
1.520
 Why?
Lung Neoplasms
10
2023
2328
1.450
 Why?
Anilides
6
2024
73
1.440
 Why?
Gonanes
7
2016
27
1.420
 Why?
Proto-Oncogene Proteins
6
2021
634
1.380
 Why?
Biomarkers, Tumor
8
2020
1181
1.340
 Why?
Thyroid Carcinoma, Anaplastic
3
2020
35
1.340
 Why?
Cetuximab
7
2018
93
1.330
 Why?
Adenocarcinoma
7
2024
888
1.310
 Why?
Phosphatidylinositol 3-Kinases
8
2017
357
0.870
 Why?
Mutation
13
2024
3689
0.820
 Why?
Carcinoma
3
2019
214
0.760
 Why?
Neoplasm Staging
15
2019
1290
0.740
 Why?
Phytotherapy
2
2012
75
0.730
 Why?
Drugs, Investigational
2
2011
32
0.730
 Why?
Cisplatin
6
2024
297
0.720
 Why?
Pyrazoles
5
2023
404
0.680
 Why?
Disease-Free Survival
10
2017
647
0.670
 Why?
Neoplasms, Second Primary
1
2021
108
0.660
 Why?
Papillomaviridae
4
2019
113
0.660
 Why?
Antineoplastic Agents, Immunological
2
2018
175
0.660
 Why?
Quinolines
5
2024
153
0.650
 Why?
Carcinoma, Renal Cell
3
2017
179
0.650
 Why?
Taxoids
3
2015
95
0.650
 Why?
Humans
89
2024
128417
0.640
 Why?
Hedgehog Proteins
3
2015
187
0.630
 Why?
Drug Resistance, Neoplasm
8
2024
749
0.620
 Why?
Marijuana Smoking
2
2012
239
0.590
 Why?
Tumor Suppressor Proteins
2
2018
313
0.590
 Why?
Middle Aged
43
2024
30889
0.590
 Why?
Pyrimidines
5
2023
445
0.590
 Why?
Colorectal Neoplasms
2
2016
746
0.570
 Why?
Aged
39
2024
21953
0.570
 Why?
Kidney Neoplasms
3
2017
349
0.560
 Why?
Carcinoma, Mucoepidermoid
1
2017
16
0.550
 Why?
Ubiquitin Thiolesterase
1
2017
42
0.540
 Why?
Carcinoma, Transitional Cell
4
2017
60
0.530
 Why?
Carcinoma, Ductal
1
2016
11
0.530
 Why?
Adenoma, Pleomorphic
1
2016
9
0.530
 Why?
Cannabinoids
2
2024
129
0.520
 Why?
Sulfones
2
2014
108
0.520
 Why?
Gene Rearrangement
2
2018
146
0.520
 Why?
Glycine
2
2014
164
0.510
 Why?
Maximum Tolerated Dose
5
2017
192
0.480
 Why?
Enzyme Inhibitors
3
2014
809
0.450
 Why?
Drug Interactions
6
2017
357
0.440
 Why?
Melanoma
1
2021
752
0.440
 Why?
Pyrroles
1
2014
191
0.430
 Why?
Male
44
2024
62857
0.430
 Why?
Signal Transduction
8
2018
4826
0.430
 Why?
Iodine Radioisotopes
5
2024
142
0.420
 Why?
Gene Fusion
3
2023
24
0.420
 Why?
Phenylurea Compounds
4
2024
89
0.420
 Why?
Receptor Protein-Tyrosine Kinases
2
2012
221
0.410
 Why?
Genetic Variation
1
2018
933
0.410
 Why?
Female
45
2024
68153
0.410
 Why?
Lymph Nodes
4
2017
466
0.400
 Why?
Indazoles
3
2019
64
0.400
 Why?
Aged, 80 and over
15
2024
7033
0.390
 Why?
Treatment Outcome
15
2024
10151
0.390
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2017
81
0.380
 Why?
Quinazolines
1
2013
243
0.380
 Why?
Antibodies, Monoclonal, Humanized
4
2024
755
0.380
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2012
111
0.370
 Why?
Neoplasm Metastasis
6
2021
608
0.350
 Why?
Proto-Oncogene Proteins c-ret
4
2023
29
0.340
 Why?
Adult
26
2024
35299
0.340
 Why?
Prognosis
9
2021
3772
0.310
 Why?
Papillomavirus Infections
3
2022
290
0.300
 Why?
ErbB Receptors
4
2017
601
0.300
 Why?
Pharmacogenomic Variants
2
2018
35
0.290
 Why?
Nitriles
2
2022
157
0.280
 Why?
Urologic Neoplasms
2
2017
25
0.270
 Why?
Xenograft Model Antitumor Assays
7
2024
814
0.270
 Why?
Carcinoma, Ductal, Breast
1
2007
82
0.270
 Why?
Platinum
2
2024
44
0.270
 Why?
Mitoxantrone
1
2006
14
0.270
 Why?
Enterobacter
1
2006
7
0.260
 Why?
Tooth Diseases
1
2006
13
0.260
 Why?
Gene Expression Profiling
5
2018
1688
0.250
 Why?
Esophageal and Gastric Varices
1
2006
36
0.250
 Why?
Enterobacteriaceae Infections
1
2006
36
0.250
 Why?
Benzamides
2
2019
194
0.250
 Why?
Animals
16
2024
34479
0.250
 Why?
Salivary Glands
2
2023
29
0.250
 Why?
Oropharyngeal Neoplasms
2
2016
48
0.250
 Why?
Acute Kidney Injury
3
2018
773
0.250
 Why?
Chemoradiotherapy
4
2020
209
0.240
 Why?
Clinical Trials as Topic
3
2018
993
0.240
 Why?
Registries
2
2016
1877
0.240
 Why?
Serotonin 5-HT3 Receptor Antagonists
1
2024
5
0.240
 Why?
Proto-Oncogene Proteins B-raf
2
2024
214
0.230
 Why?
Cannabis
1
2011
429
0.230
 Why?
Immunotherapy
2
2023
587
0.230
 Why?
Receptors, Estrogen
1
2007
424
0.230
 Why?
Antiemetics
1
2024
39
0.230
 Why?
Urinary Bladder Neoplasms
2
2017
226
0.220
 Why?
Models, Biological
3
2024
1691
0.220
 Why?
Liver Cirrhosis
1
2006
275
0.220
 Why?
Bacteremia
1
2006
190
0.220
 Why?
Carcinoma, Adenoid Cystic
1
2023
17
0.220
 Why?
Combined Modality Therapy
4
2018
1204
0.220
 Why?
Gene Expression Regulation, Neoplastic
3
2019
1351
0.220
 Why?
Administration, Oral
3
2014
754
0.210
 Why?
Phenylthiohydantoin
1
2022
44
0.200
 Why?
Survival Rate
5
2021
1869
0.190
 Why?
Medical Marijuana
1
2024
107
0.190
 Why?
Referral and Consultation
1
2007
727
0.190
 Why?
Breast Neoplasms
2
2019
2132
0.190
 Why?
Drug Evaluation, Preclinical
2
2013
168
0.190
 Why?
Chemotherapy, Adjuvant
3
2017
376
0.190
 Why?
Radiation Pneumonitis
1
2021
28
0.190
 Why?
Survival Analysis
4
2020
1263
0.190
 Why?
Carcinoma, Neuroendocrine
1
2021
32
0.180
 Why?
TOR Serine-Threonine Kinases
2
2016
380
0.180
 Why?
Adrenal Cortex Neoplasms
1
2021
60
0.170
 Why?
Adrenocortical Carcinoma
1
2021
63
0.170
 Why?
Disease Susceptibility
2
2020
331
0.170
 Why?
SEER Program
1
2021
206
0.170
 Why?
Cystectomy
2
2017
38
0.170
 Why?
Gene Expression
2
2015
1456
0.170
 Why?
Receptors, Nerve Growth Factor
1
2019
16
0.170
 Why?
Kaplan-Meier Estimate
3
2017
853
0.170
 Why?
United States
8
2021
13830
0.160
 Why?
Leukemia, Myeloid, Acute
1
2006
591
0.160
 Why?
Radiosurgery
1
2022
318
0.160
 Why?
DNA Mutational Analysis
2
2018
384
0.160
 Why?
Tracheal Neoplasms
1
2019
10
0.160
 Why?
Positron Emission Tomography Computed Tomography
1
2020
84
0.160
 Why?
Lymph Node Excision
2
2017
165
0.160
 Why?
Smad4 Protein
1
2019
37
0.150
 Why?
Prostatic Neoplasms
1
2006
1011
0.150
 Why?
Genetic Heterogeneity
1
2019
57
0.150
 Why?
Benzazepines
1
2018
40
0.150
 Why?
Genomics
3
2021
715
0.150
 Why?
Alphapapillomavirus
2
2016
40
0.150
 Why?
Palliative Care
2
2018
713
0.150
 Why?
Disease Management
2
2020
587
0.150
 Why?
Risk
1
2021
853
0.150
 Why?
Chromosome Aberrations
1
2019
148
0.150
 Why?
DNA Mismatch Repair
1
2018
47
0.150
 Why?
Receptor, ErbB-2
2
2019
325
0.150
 Why?
Tissue Fixation
1
2017
33
0.140
 Why?
Paraffin Embedding
1
2017
27
0.140
 Why?
Oncogenes
1
2018
109
0.140
 Why?
Erlotinib Hydrochloride
1
2017
69
0.140
 Why?
Smokers
1
2018
137
0.140
 Why?
Formaldehyde
1
2017
57
0.140
 Why?
Nasopharyngeal Neoplasms
1
2017
16
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
128
0.140
 Why?
Gene Deletion
1
2019
370
0.140
 Why?
Health Services Needs and Demand
1
2019
264
0.140
 Why?
Neoplasm Grading
1
2018
283
0.140
 Why?
DNA, Neoplasm
1
2017
159
0.140
 Why?
Induction Chemotherapy
1
2017
70
0.130
 Why?
Gene Frequency
1
2018
504
0.130
 Why?
Chemoradiotherapy, Adjuvant
1
2016
41
0.130
 Why?
Salivary Ducts
1
2016
2
0.130
 Why?
Hospice and Palliative Care Nursing
1
2018
74
0.130
 Why?
Laryngeal Neoplasms
1
2016
29
0.130
 Why?
Patient Navigation
1
2018
79
0.130
 Why?
Prospective Studies
7
2024
7036
0.130
 Why?
Carboplatin
1
2016
140
0.130
 Why?
Muscle, Smooth
1
2017
145
0.130
 Why?
Nomograms
1
2016
47
0.130
 Why?
Young Adult
5
2021
12312
0.130
 Why?
Dose-Response Relationship, Drug
3
2017
1936
0.130
 Why?
Population Surveillance
1
2019
427
0.130
 Why?
Database Management Systems
1
2016
48
0.130
 Why?
Disease Progression
4
2018
2602
0.130
 Why?
Retrospective Studies
8
2021
14454
0.130
 Why?
Computational Biology
2
2018
598
0.130
 Why?
Incidence
2
2019
2616
0.120
 Why?
Angiopoietin-1
1
2015
11
0.120
 Why?
Angiopoietin-2
1
2015
15
0.120
 Why?
Radiotherapy
1
2016
185
0.120
 Why?
Bone Neoplasms
1
2017
229
0.120
 Why?
Genetic Testing
1
2018
428
0.120
 Why?
Zinc Finger Protein GLI1
1
2014
24
0.120
 Why?
Retreatment
1
2014
69
0.120
 Why?
Hospice Care
1
2018
198
0.120
 Why?
Piperazines
2
2018
336
0.120
 Why?
Neoplasms, Unknown Primary
1
2014
13
0.110
 Why?
Response Evaluation Criteria in Solid Tumors
1
2014
17
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2016
421
0.110
 Why?
Paclitaxel
1
2015
214
0.110
 Why?
Neoplastic Stem Cells
1
2018
386
0.110
 Why?
Patient Satisfaction
1
2018
641
0.110
 Why?
High-Throughput Nucleotide Sequencing
1
2017
484
0.110
 Why?
Pilot Projects
2
2015
1563
0.110
 Why?
Sulfonamides
1
2017
499
0.110
 Why?
Proportional Hazards Models
4
2017
1196
0.110
 Why?
Promoter Regions, Genetic
1
2018
1198
0.110
 Why?
Veratrum Alkaloids
1
2013
19
0.110
 Why?
ras Proteins
1
2014
145
0.110
 Why?
Cell Cycle Proteins
2
2014
577
0.100
 Why?
PTEN Phosphohydrolase
1
2014
157
0.100
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
258
0.100
 Why?
Imatinib Mesylate
1
2012
66
0.100
 Why?
Risk Assessment
2
2019
3232
0.100
 Why?
Dasatinib
1
2012
51
0.100
 Why?
Recombinant Fusion Proteins
1
2015
634
0.100
 Why?
Thiazoles
1
2012
115
0.100
 Why?
Hematopoietic Stem Cells
1
2015
378
0.100
 Why?
Aniline Compounds
1
2012
98
0.100
 Why?
Biomarkers
3
2018
3880
0.090
 Why?
Mice
7
2024
16602
0.090
 Why?
Smoking
1
2019
1460
0.090
 Why?
Biological Availability
1
2011
122
0.090
 Why?
Proto-Oncogene Proteins c-met
1
2012
74
0.090
 Why?
Imidazoles
1
2012
226
0.090
 Why?
Adolescent
5
2022
20179
0.090
 Why?
Propensity Score
3
2017
264
0.090
 Why?
Carcinoma, Basal Cell
1
2012
73
0.090
 Why?
Phosphatidylinositol 3-Kinase
1
2011
26
0.090
 Why?
Evidence-Based Medicine
2
2012
711
0.090
 Why?
Vascular Endothelial Growth Factor A
2
2024
500
0.090
 Why?
Tumor Microenvironment
1
2015
623
0.090
 Why?
Cell Line, Tumor
4
2024
3184
0.090
 Why?
Algorithms
1
2018
1618
0.090
 Why?
Phenotype
1
2018
3044
0.080
 Why?
Genetic Predisposition to Disease
1
2018
2264
0.080
 Why?
Kidney
1
2017
1302
0.080
 Why?
Adaptation, Psychological
1
2014
616
0.080
 Why?
Brain Neoplasms
1
2018
1163
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2024
89
0.080
 Why?
Multivariate Analysis
3
2017
1484
0.080
 Why?
Cohort Studies
4
2022
5388
0.070
 Why?
Axilla
1
2007
43
0.070
 Why?
Neoadjuvant Therapy
2
2022
381
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2019
50
0.070
 Why?
RNA, Messenger
1
2014
2675
0.070
 Why?
Caregivers
1
2014
810
0.070
 Why?
Sentinel Lymph Node Biopsy
1
2007
108
0.070
 Why?
Mastectomy
1
2007
131
0.070
 Why?
Transcription Factors
1
2014
1628
0.070
 Why?
Ligation
1
2006
86
0.060
 Why?
Stress, Psychological
1
2014
1059
0.060
 Why?
Creatinine
2
2018
475
0.060
 Why?
Pain
1
2011
757
0.060
 Why?
Fatal Outcome
1
2006
300
0.060
 Why?
Lymphatic Metastasis
2
2017
318
0.060
 Why?
Neoplasm Invasiveness
2
2017
480
0.060
 Why?
Double-Blind Method
2
2021
1848
0.060
 Why?
Receptors, Progesterone
1
2007
341
0.060
 Why?
Granisetron
1
2024
5
0.060
 Why?
Quinuclidines
1
2024
9
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
119
0.060
 Why?
Ondansetron
1
2024
15
0.060
 Why?
Risk Factors
1
2019
9704
0.060
 Why?
Isoquinolines
1
2024
41
0.060
 Why?
Skin Neoplasms
1
2012
832
0.060
 Why?
Neoplasm Proteins
1
2007
421
0.060
 Why?
Glomerular Filtration Rate
2
2018
681
0.060
 Why?
Demography
2
2015
277
0.060
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2023
81
0.050
 Why?
Benzimidazoles
1
2024
157
0.050
 Why?
Recurrence
2
2018
996
0.050
 Why?
Databases, Factual
2
2019
1269
0.050
 Why?
Androgen Antagonists
1
2022
79
0.050
 Why?
Four-Dimensional Computed Tomography
1
2021
28
0.050
 Why?
Quality of Life
1
2013
2680
0.050
 Why?
Immunohistochemistry
2
2018
1664
0.050
 Why?
Pulmonary Ventilation
1
2021
76
0.050
 Why?
Receptors, Androgen
1
2022
143
0.050
 Why?
Radiotherapy Planning, Computer-Assisted
1
2021
123
0.040
 Why?
Receptor, trkA
1
2019
16
0.040
 Why?
Receptor, trkC
1
2019
10
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
71
0.040
 Why?
Receptor, trkB
1
2019
31
0.040
 Why?
Trastuzumab
1
2019
100
0.040
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2020
163
0.040
 Why?
Radiotherapy, Image-Guided
1
2018
33
0.040
 Why?
Phthalazines
1
2018
40
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
313
0.040
 Why?
Organic Cation Transporter 2
1
2017
8
0.040
 Why?
Glutathione S-Transferase pi
1
2017
9
0.040
 Why?
Multidrug Resistance-Associated Proteins
1
2017
36
0.040
 Why?
Retroperitoneal Space
1
2017
16
0.040
 Why?
Organic Cation Transport Proteins
1
2017
26
0.030
 Why?
Urinary Diversion
1
2017
12
0.030
 Why?
Membrane Glycoproteins
1
2019
466
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
43
0.030
 Why?
Margins of Excision
1
2017
37
0.030
 Why?
Social Work
1
2018
83
0.030
 Why?
Tumor Cells, Cultured
1
2019
930
0.030
 Why?
Laryngectomy
1
2016
14
0.030
 Why?
Immunophenotyping
1
2018
311
0.030
 Why?
Oncologists
1
2017
35
0.030
 Why?
Hospitals, Veterans
1
2018
256
0.030
 Why?
Kidney Function Tests
1
2017
145
0.030
 Why?
Disease Models, Animal
2
2018
3937
0.030
 Why?
Pelvis
1
2017
101
0.030
 Why?
Carcinogenesis
1
2018
209
0.030
 Why?
Viral Core Proteins
1
2016
21
0.030
 Why?
Cation Transport Proteins
1
2017
129
0.030
 Why?
Anti-Bacterial Agents
1
2006
1663
0.030
 Why?
Regression Analysis
1
2018
978
0.030
 Why?
Heart
1
2020
635
0.030
 Why?
Radiotherapy, Adjuvant
1
2016
209
0.030
 Why?
Internationality
1
2016
148
0.030
 Why?
Random Allocation
1
2016
343
0.030
 Why?
Robotic Surgical Procedures
1
2017
109
0.030
 Why?
Antibodies, Neoplasm
1
2015
35
0.030
 Why?
Biopsy, Large-Core Needle
1
2014
13
0.030
 Why?
Myocardium
1
2020
965
0.030
 Why?
Analysis of Variance
1
2017
1269
0.030
 Why?
Bone Marrow
1
2015
267
0.030
 Why?
Receptor, Notch2
1
2013
15
0.030
 Why?
Receptor Cross-Talk
1
2013
21
0.030
 Why?
Receptor, Notch1
1
2013
61
0.030
 Why?
Pandemics
1
2021
1476
0.030
 Why?
Metabolic Clearance Rate
1
2012
103
0.020
 Why?
Gene Silencing
1
2013
185
0.020
 Why?
Psychiatric Status Rating Scales
1
2014
527
0.020
 Why?
Transcriptome
1
2018
881
0.020
 Why?
Needs Assessment
1
2014
359
0.020
 Why?
Nausea
1
2012
107
0.020
 Why?
Logistic Models
1
2017
1974
0.020
 Why?
Area Under Curve
1
2012
279
0.020
 Why?
Vomiting
1
2012
126
0.020
 Why?
Diarrhea
1
2012
177
0.020
 Why?
Mice, Nude
1
2013
682
0.020
 Why?
Blotting, Western
1
2013
1164
0.020
 Why?
Drug Administration Schedule
1
2012
751
0.020
 Why?
Fatigue
1
2012
317
0.020
 Why?
Cell Proliferation
1
2017
2344
0.020
 Why?
Time Factors
1
2019
6482
0.020
 Why?
Lung
1
2021
3743
0.020
 Why?
Age Factors
1
2016
3103
0.020
 Why?
Colorado
1
2018
4375
0.020
 Why?
Follow-Up Studies
1
2016
4892
0.020
 Why?
Cytokines
1
2015
1983
0.020
 Why?
Surveys and Questionnaires
1
2018
5362
0.020
 Why?
Cross-Sectional Studies
1
2014
5039
0.010
 Why?
Bowles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (347) concept(s)
_
Co-Authors Expand Description
See all (68) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)